Reprint

20th Anniversary of Pharmaceuticals

Advances in Pathophysiology, Pharmacology and Neuroprotection in Glaucoma

Edited by
October 2025
284 pages
  • ISBN 978-3-7258-5335-9 (Hardback)
  • ISBN 978-3-7258-5336-6 (PDF)

This is a Reprint of the Special Issue 20th Anniversary of Pharmaceuticals—Advances in Pathophysiology, Pharmacology and Neuroprotection in Glaucoma that was published in

Biology & Life Sciences
Public Health & Healthcare
Medicine & Pharmacology
Summary

The Special Issue Reprint encompassing peer-reviewed articles on glaucoma and neuroprotection is timely, as the constellation of eye diseases is ever-increasing as the world’s population ages. The aim of the Special Issue was to capture some leading aspects of on-going research into pathophysiology, genetics and current and future therapeutic treatment options to mitigate the signs and symptoms of these potentially blinding disorders, especially open-angle and normotensive glaucoma that affect millions worldwide. I hope that this collection of original research and review articles will spur further interest in these elements in the academic arena and in the biopharmaceutical industries.

Related Books

May 2025

Glaucoma

Medicine & Pharmacology
November 2023

Going for Gaps in Glaucoma

Medicine & Pharmacology

The recommendations have been generated using an AI system.